ReviewMikrochimica acta2025
Advances in molecularly imprinted polymers for clinical biomarker detection (2021-2025).
Review in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The growing demand for early and precise disease diagnosis has made biomarker detection a vital component of modern precision medicine. However, conventional detection methods often struggle with cost, scalability, and robustness in complex biological samples. Molecularly imprinted polymers (MIPs), synthetic biorecognition materials that mimic natural molecular recognition mechanisms, have emerged as a transformative solution and gained increasing attention from the scientific community. MIPs are created by forming specific recognition sites within the polymer matrix using target molecules as templates. These sites enable MIPs to recognize the target molecules with high sensitivity and specificity, making them highly promising for applications in biomarker detection. The aim of this review is to comprehensively summarize the latest research on the application of MIPs in clinical diagnostic biomarker assays from 2021 to 2025, with a particular focus on (1) composition and structure of MIPs; (2) preparation methods; and (3) the use of MIPs for biomarker detection. Through an in-depth analysis of these studies, this review endeavors to provide valuable insights and guidance for future medical research and clinical applications involving MIPs.
Indexed as
Identifiers
40783452What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.